Robin Lynge

Robin Lynge has extensive work experience in the biopharmaceutical industry. They are currently working as a Senior Director of Business Development at Rentschler Biopharma SE, starting in 2023. Prior to this role, they had various positions at Catalent Pharma Solutions, including Associate Director of Project Management, Regional Director of Sales and Business Development for Biologics Analytical Testing, and Director of Commercial Development for Biologics Analytical. Before joining Catalent, Robin worked at Alcami Corporation as a Director of Account and Project Management and Director of Sales and Business Development for Lab Services. Their earlier experience includes roles at AAIPharma Services Corp./Cambridge Major Laboratories Inc., such as Senior Manager of Project Management & Inside Sales, Associate Manager of Sales Operations, Supervisor of Sales Operations, Technical Resource Specialist, Project Manager, and Associate Scientist.

Robin Lynge earned a Bachelor of Science degree in Pharmaceutical Sciences from Campbell University, where they studied from 1994 to 1998. Later, they pursued a Master's degree in Chemistry from the University of North Carolina Wilmington, completing their studies in 2009.